Q3 2017
Released Nov 13, 2017, during market hours
10-Q filed Nov 13, 2017, 44 days after period end · 0001493152-17-012867
Q3 2017 · 10-Q
Revenue$3.04M$3.04M +116.8% vs Q3 2016+59.6% vs Q2 2017
Net Income-$777.00K-$777.00K N/M vs Q3 2016N/M vs Q2 2017
EPS Diluted-$0.05-$0.05 N/M vs Q3 2016N/M vs Q2 2017
Gross Profit$432,000+119.3%
Operating Income-$902,000N/M
Operating Cash Flowderived-$445,000N/M
Free Cash Flowderived-$515,000N/M
Margins · derived
Gross margin14.2%+0.2 pt vs Q3 2016
Operating margin-29.7%+26.4 pt vs Q3 2016
Net margin-25.6%−37.5 pt vs Q3 2016
What the release said
The release
Same quarter
| Metric | Q3 2017 | Q3 2016 | Q3 2015 | Q3 2014 |
|---|---|---|---|---|
| Revenue | $3.04M | $1.40M | $4.39M | $5.13M |
| Net Income | -$777.00K | $167.00K | $602.00K | -$3.22M |
| EPS Diluted | -$0.05 | $0.01 | $0.04 | -$0.18 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
ProPhase Labs, Inc. · CIK 868278 · Engraved from SEC EDGAR